Add like
Add dislike
Add to saved papers

MicroRNA-18a promotes proliferation and metastasis in oral squamous cell carcinoma via targeting KLF4.

Oral squamous cell carcinoma (OSCC) is a complex disease with extensive genetic and epigenetic defects, including microRNA deregulation. The aims of the present study were to explore the regulatory mechanism of microRNA-18a in OSCC cells proliferation and metastasis. Quantitative real-time PCR (qRT-PCR) was used to detect the expression level of miR-18a and KLF4 mRNA in OSCC tissues and cell lines (SCC-25, CAL-27, Tca-8113). Western-blot analysis was used to validate expression of KLF4 protein. CCK-8 assay was performed to e validate the proliferous ability of human OSCC cells. Transwell assays were performed to determine the migratory and invasive abilities of OSCC in vitro. Dual-luciferase reporter assay, qRT-PCR and Western-blot were used to confirm that miR-18a regulates KLF4 expression in OSCC. miR-18a was significantly up-regulated in human OSCC cell lines (SCC-25, CAL-27, and Tca-8113) and clinical OSCC specimens. miR-18a over-expression markedly promoted human OSCC cell proliferation, invasion, migration in vitro. Bioinformatics analysis made a prediction that KLF4 was the candidate target gene of miR-18a, and western blotting confirmed the negative correlation between miR-18a and KLF4. Additionally, KLF4 was negatively associated with miR-18a in OSCC and abnormal expression of KLF4 attenuated miR-18a-mediated promotion in cell proliferation. In conclusmiR-18a p ion, remoted OSCC proliferation, migration and invasion abilities and suppressed the expression of, KLF4. This newly identified miR-18a/KLF4 axis may provide new insight into the pathogenesis and offers a potential target for OSCC therapy.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app